Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers.
Types of 2-nitroimidazoles and 3-nitro-1,2,4-triazoles bearing one or two fluorine atoms on their side chains were synthesized to evaluate their physicochemical properties, radiosensitizing effects, and toxicity. The reduction potential of the compounds containing one fluorine was similar to that of misonidazole (MISO), whereas that of the difluorinated compounds was slightly higher. Both mono- and difluorinated compounds had an in vitro sensitizing activity comparable to or slightly higher than that of MISO. The fluorinated 3-nitrotriazoles were almost as efficient as the 2-nitroimidazoles with the same substituent. In vivo, some of the compounds were up to twice more efficient than MISO, whereas others were as efficient as MISO. Toxicity in terms of LD50/7 in mice was quite variable depending on the side-chain structure; the amide derivatives were less toxic than MISO, whereas the alcohol and ether derivatives were more toxic. In view of the radiosensitizing effect and toxicity in vivo, at least one compound, KU-2285 (a 2-nitroimidazole with an N1-substituent of: CH2CF2CONHCH2CH2OH) has been found to be as useful a hypoxic cell sensitizer as SR-2508.
Shibamoto
Y
Y
Department of Radiology, Faculty of Medicine, Kyoto University, Japan.
Nishimoto
S
S
Shimokawa
K
K
Hisanaga
Y
Y
Zhou
L
L
Wang
J
J
Sasai
K
K
Takahashi
M
M
Abe
M
M
Kagiya
T
T
D000818:Animals; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D003131:Combined Modality Therapy; D006845:Hydrocarbons, Fluorinated / Q000138:chemical synthesis / Q000627:therapeutic use* / Q000633:toxicity; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000532:radiotherapy*; D009593:Nitroimidazoles / Q000138:chemical synthesis / Q000627:therapeutic use*; D010100:Oxygen / Q000378:metabolism*; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage* / Q000633:toxicity; D014230:Triazoles / Q000138:chemical synthesis / Q000627:therapeutic use*
D006845:Hydrocarbons, Fluorinated; D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; D014230:Triazoles; D010100:Oxygen